NNFTF yields 2.35% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, NNFTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NNFTF + JNJ for your $10,000?
Nanofilm Technologies International Limited, together with its subsidiaries, provides nanotechnology solutions in Singapore, China, Japan, and Vietnam. The company operates through three segments: Advanced Materials, Industrial Equipment, and Nanofabrication. The Advanced Materials segment offers advanced materials through surface solution services based on its vacuum coating technologies and processes. The Industrial Equipment segment manufactures and sells turnkey equipment systems comprising coating equipment, cleaning lines, and automation systems that are installed at its customers' production lines. This segment also provides customized operating software for its systems and training, as well as spare-parts, customer service, and other forms of after-sales support. The Nanofabrication segment manufactures and supplies nanoproducts, which are used by its customers as components for the smooth functioning and performance of various parts of their end-products. The company is also involved in the marketing and sale of industrial machinery and equipment; research and experimental development on engineering; research and development, engineering, and production hydrogen application and products; manufacture and supply of dies, moulds, tools, jigs, and fixtures; and provision of coating services to end users in the precision engineering and printed circuit boards industry, as well as coating services for precision components and automotive parts. In addition, it engages in solar cell business; the provision of consultation and technical development services; the manufacture and forming of modules; manufacture, processing, and assembly of plastic products; production and sale of auto parts; and trading and sale of electronics and equipment. The company was incorporated in 1999 and is headquartered in Singapore.
Full NNFTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.